1 Vanguard ETF That Could Soar 27.1% Before the End of 2024, According to a Top Wall Street Analyst [Yahoo! Finance]
Vaxcyte, Inc. (PCVX)
Company Research
Source: Yahoo! Finance
But Tom Lee from Fundstrat Global Advisors is on a hot streak, with a series of very accurate calls over the last couple of years. He predicted the S&P 500 (SNPINDEX: ^GSPC) would climb to 4,750 in 2023, while many other analysts had a negative outlook, and it ended the year at 4,769. Plus, three of his S&P 500 targets for 2024 have already been surpassed (5,200, 5,500, and 5,700), and the index is now less than 2% away from hitting his most recent target of 6,000. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Lee also came into 2024 with a bullish target for the Russell 2000 index, which features approximately 2,000 of the smallest companies listed on American stock exchanges. He believed falling interest rates and the cheap valuations among small-cap stocks would carry the index to a 50% gain in 2024. His prediction might have received another boost thanks to President-Elect Trump's election win. The Russell 2000
Show less
Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCVX alerts
High impacting Vaxcyte, Inc. news events
Weekly update
A roundup of the hottest topics
PCVX
News
- Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult ProgramsGlobeNewswire
- We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely [Yahoo! Finance]Yahoo! Finance
- Vaxcyte, Inc. (NASDAQ: PCVX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.MarketBeat
- Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight [Yahoo! Finance]Yahoo! Finance
PCVX
Earnings
- 11/5/24 - Beat
PCVX
Sec Filings
- 11/12/24 - Form SC
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- PCVX's page on the SEC website